转移性肢端黑色素瘤的临床试验
总计692个结果
-
Centre Hospitalier Universitaire de Nice招聘中
-
Centre Hospitalier Universitaire Vaudois主动,不招人
-
Providence Health & ServicesPrometheus Laboratories主动,不招人
-
The Netherlands Cancer InstituteCopenhagen University Hospital at Herlev主动,不招人
-
Canadian Cancer Trials GroupMerck Sharp & Dohme LLC终止
-
Iovance Biotherapeutics, Inc.主动,不招人
-
Novartis Pharmaceuticals终止
-
F. Stephen Hodi, MDMedImmune LLC完全的
-
The Christie NHS Foundation TrustNational Institute for Health Research, United Kingdom终止
-
Biocad主动,不招人黑色素瘤 | 黑色素瘤转移俄罗斯联邦, 白俄罗斯
-
Netherlands Working Group on Immunotherapy of OncologyHoffmann-La Roche; Amsterdam UMC, location VUmc; The Netherlands Cancer Institute终止
-
Nektar TherapeuticsImaginAb, Inc.撤销
-
OncoImmune, Inc.National Cancer Institute (NCI); Huntsman Cancer Institute撤销
-
BioNTech US Inc.Apexigen, Inc.终止
-
Nantes University HospitalUMR892完全的
-
Providence Health & ServicesProvidence Cancer Center, Earle A. Chiles Research Institute; Galectin Therapeutics Inc.完全的
-
Melanoma Research Foundation Breakthrough ConsortiumGenentech, Inc.终止
-
Istituto Oncologico Veneto IRCCSJanssen Diagnostics, LLC未知
-
National Center for Tumor Diseases, HeidelbergUniversity Hospital Heidelberg完全的
-
Hoag Memorial Hospital Presbyterian完全的
-
Haukeland University HospitalHoffmann-La Roche; Norwegian Cancer Society完全的
-
Duke University终止
-
Yale UniversityNovartis终止
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb完全的
-
California Pacific Medical Center Research Institute完全的
-
Millennium Pharmaceuticals, Inc.完全的
-
M.D. Anderson Cancer CenterAventis Pharmaceuticals完全的
-
Molecular Insight Pharmaceuticals, Inc.终止
-
Pierre Fabre Medicament完全的黑色素瘤 | BRAF V600E 不可切除或转移性黑色素瘤 | BRAF V600E 转移性非小细胞肺癌中国
-
IDEAYA Biosciences招聘中